Adipose tissue in older individuals: A contributing factor to sarcopenia
With Mounjaro on the way in 2024 a similar drug, using tirzepatide, thats supposedly even more powerful a revolution seems underway, one where obesity has been conquered by pharmaceuticals once and for all
In the UK, it is licensed for major depressive episodes, obsessive-compulsive disorder (OCD), and bulimia nervosa
This triple action may reduce appetite, increase fullness, support blood sugar control and influence how the body uses energy
L.BalzsM.CaplaziP.et al (2011)
Some individuals may require higher or more frequent doses through IV glutathione therapy, while others may benefit from standard intramuscular injections